S V Kane

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. doi request reprint Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experience
    S V Kane
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 18:2203-8. 2012
  2. doi request reprint What physicians don't know about patient dietary beliefs and behavior can make a difference
    Sunanda Kane
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Rochester, 200 First St SW, Rochester, MN 55905, USA
    Expert Rev Gastroenterol Hepatol 6:545-7. 2012
  3. doi request reprint Strategies in maintenance for patients receiving long-term therapy (SIMPLE): a study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis
    Sunanda Kane
    Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 18:1026-33. 2012
  4. doi request reprint Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease
    Sunanda Kane
    Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota55905, USA
    Am J Gastroenterol 107:154-60. 2012
  5. doi request reprint Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients
    Sunanda V Kane
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Adv Ther 26:936-46. 2009
  6. ncbi request reprint The challenge of compliance and persistence: focus on ulcerative colitis
    Sunanda V Kane
    Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, 200 First Street, SW, 19th Floor, Rochester, MN 55905, USA
    J Manag Care Pharm 14:s2-12; quiz s13-5. 2008
  7. doi request reprint Abnormal Pap smears in inflammatory bowel disease
    Sunanda Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 14:1158-60. 2008
  8. doi request reprint Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery
    Sunanda Kane
    Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Gastroenterol 43:613-6. 2009
  9. doi request reprint Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy
    Sunanda V Kane
    Division of Gastroenterology and Hepatology, Miles and Shirley Fiterman Center, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Am J Gastroenterol 104:228-33. 2009
  10. doi request reprint Strategies to improve adherence and outcomes in patients with ulcerative colitis
    Sunanda V Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Drugs 68:2601-9. 2008

Collaborators

Detail Information

Publications53

  1. doi request reprint Natalizumab for moderate to severe Crohn's disease in clinical practice: the Mayo Clinic Rochester experience
    S V Kane
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 18:2203-8. 2012
    ..Natalizumab, a monoclonal antibody to alpha-4 integrin approved for CD, has demonstrated efficacy in randomized clinical trials. We describe our experience with natalizumab in clinical practice at Mayo Clinic Rochester...
  2. doi request reprint What physicians don't know about patient dietary beliefs and behavior can make a difference
    Sunanda Kane
    Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic Rochester, 200 First St SW, Rochester, MN 55905, USA
    Expert Rev Gastroenterol Hepatol 6:545-7. 2012
    ..Sixty seven percent reported purposely avoiding certain foods that they usually liked in order to prevent relapse. The majority of patients avoid eating certain foods and report that food has a strong impact on social life...
  3. doi request reprint Strategies in maintenance for patients receiving long-term therapy (SIMPLE): a study of MMX mesalamine for the long-term maintenance of quiescent ulcerative colitis
    Sunanda Kane
    Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 18:1026-33. 2012
    ..A secondary outcome was the relationship between long-term efficacy and adherence...
  4. doi request reprint Use of a screening tool to determine nonadherent behavior in inflammatory bowel disease
    Sunanda Kane
    Department of Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota55905, USA
    Am J Gastroenterol 107:154-60. 2012
    ..We aimed to determine whether scores from a self-reported adherence survey correlated with pharmacy refill data as a reliable measure of medication adherence...
  5. doi request reprint Adherence to infliximab maintenance therapy and health care utilization and costs by Crohn's disease patients
    Sunanda V Kane
    Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Adv Ther 26:936-46. 2009
    ..The aim of this analysis was to evaluate adherence to infliximab maintenance therapy and the impact of medication adherence on health care utilization and costs by patients with CD...
  6. ncbi request reprint The challenge of compliance and persistence: focus on ulcerative colitis
    Sunanda V Kane
    Mayo Clinic College of Medicine, Division of Gastroenterology and Hepatology, 200 First Street, SW, 19th Floor, Rochester, MN 55905, USA
    J Manag Care Pharm 14:s2-12; quiz s13-5. 2008
    ..An estimated 20% to 50% of patients with ulcerative colitis (UC) do not take their medications as prescribed, resulting in higher disease-recurrence rates and potentially higher health care costs...
  7. doi request reprint Abnormal Pap smears in inflammatory bowel disease
    Sunanda Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic School of Medicine, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 14:1158-60. 2008
    ..This review summarizes the data known for this relationship in women with IBD, and management strategies for patients found to have abnormal cervical cytology...
  8. doi request reprint Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn's disease before and after delivery
    Sunanda Kane
    Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    J Clin Gastroenterol 43:613-6. 2009
    ..The objective of this study was to determine whether infliximab, an antitumor necrosis factor monoclonal antibody, is transferred in utero or through breast milk from nursing Crohn's disease patients to their newborns...
  9. doi request reprint Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy
    Sunanda V Kane
    Division of Gastroenterology and Hepatology, Miles and Shirley Fiterman Center, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Am J Gastroenterol 104:228-33. 2009
    ..Understanding the mechanism for immunoglobulin transfer will help to understand how to minimize risk of exposure of the fetus to the therapeutic monoclonal antibody both in utero and after delivery...
  10. doi request reprint Strategies to improve adherence and outcomes in patients with ulcerative colitis
    Sunanda V Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Drugs 68:2601-9. 2008
    ....
  11. doi request reprint Disease perceptions among people with Crohn's disease
    Sunanda V Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA
    Inflamm Bowel Dis 14:1097-101. 2008
    ..We sought to characterize CD patient perceptions of both overall disease course and current symptomatology based on an objective symptom scale and to explore the relationship between perceptions and current symptoms...
  12. doi request reprint Does treatment schedule matter? Once daily versus divided doses of 5-ASAs
    Sunanda Kane
    Mayo Clinic, Rochester, MN, USA
    Dig Dis 28:478-82. 2010
    ..It thus appears that the majority of patients with UC, whether with active or quiescent disease, can be treated with once daily 5-ASA...
  13. doi request reprint Twelve-month persistency with oral 5-aminosalicylic acid therapy for ulcerative colitis: results from a large pharmacy prescriptions database
    Sunanda V Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN 55905, USA
    Dig Dis Sci 56:3463-70. 2011
    ..Patients receiving 5-aminosalicylic acid (5-ASA) require long-term therapy to achieve good outcomes. Persistency (duration of time from initiation to discontinuation of therapy) is therefore an important consideration...
  14. doi request reprint Preparing the patient for immunosuppressive therapy
    Sunanda Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 12:502-6. 2010
    ..Anti-TNFs are used for Crohn's disease and ulcerative colitis with good results; however, immune reactions, infections, and neoplasms have resulted from their use...
  15. doi request reprint Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis
    S V Kane
    Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN 55905, USA
    Aliment Pharmacol Ther 29:855-62. 2009
    ..Individuals with ulcerative colitis (UC) are at risk for poor persistence with therapy...
  16. ncbi request reprint Medication non-adherence is associated with increased medical health care costs
    Sunanda Kane
    Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Dig Dis Sci 53:1020-4. 2008
    ..Our aim was to determine the association between adherence to maintenance therapy and healthcare costs...
  17. ncbi request reprint Systematic review: adherence issues in the treatment of ulcerative colitis
    S V Kane
    Section of Gastroenterology, Department of Medicine, The University of Chicago, Chicago, IL, USA
    Aliment Pharmacol Ther 23:577-85. 2006
    ..It is a combination of understanding patient behaviour, recognizing signs of non-adherent behaviour and utilizing management strategies to change behaviour that will improve patient outcomes...
  18. ncbi request reprint The use of medications for inflammatory bowel disease during pregnancy and nursing
    Jenny Sauk
    Department of Medicine, University of Chicago, 5841 South Maryland Avenue, Chicago, IL 60637, USA
    Expert Opin Pharmacother 6:1833-9. 2005
    ..This review examines the current safety data on medications used in women with inflammatory bowel disease during pregnancy...
  19. ncbi request reprint Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis
    S V Kane
    Department of Medicine, University of Chicago, Illinois, USA
    Am J Gastroenterol 96:2929-33. 2001
    ..46 [0.39-0.57]). CONCLUSION: Nonadherence is associated with multiple concomitant medications, male gender, and single status. These patient characteristics may be helpful in targeting those patients at higher risk for nonadherence...
  20. ncbi request reprint Higher incidence of abnormal Pap smears in women with inflammatory bowel disease
    Sunanda Kane
    Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Gastroenterol 103:631-6. 2008
    ..We examined the relationship between immunomodulator use and the presence of abnormal cervical histology in women with inflammatory bowel disease (IBD)...
  21. ncbi request reprint Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis
    E V Loftus
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Aliment Pharmacol Ther 19:179-89. 2004
    ..To determine whether there is a difference in short-term adverse events in patients with ulcerative colitis treated with mesalazine, olsalazine or balsalazide...
  22. doi request reprint Once-daily dosing of delayed-release oral mesalamine (400-mg tablet) is as effective as twice-daily dosing for maintenance of remission of ulcerative colitis
    William J Sandborn
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Gastroenterology 138:1286-96, 1296.e1-3. 2010
    ..This study was conducted to determine the efficacy and safety of once-daily dosing of delayed-release mesalamine (Asacol 400-mg tablets) compared with twice-daily dosing for maintaining remission in UC patients...
  23. ncbi request reprint Inflammatory bowel diseases and management considerations: fertility and pregnancy
    Maria Moscandrew
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
    Curr Gastroenterol Rep 11:395-9. 2009
    ..Ultimately, treatment must be individualized for each patient based on the available evidence and the woman's preferences...
  24. ncbi request reprint Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Am J Med 114:39-43. 2003
    ..We conducted a prospective study to determine the effects of nonadherence with mesalamine among patients with quiescent ulcerative colitis...
  25. ncbi request reprint Novel therapies in the treatment of ulcerative colitis
    S V Kane
    Department of Medicine, Division of Gastroenterology, University of Chicago, 5841 South Maryland Ave, MC 4076, Chicago IL 60637, USA
    Expert Opin Investig Drugs 10:1223-9. 2001
    ..This review examines the most recent compounds in development for the treatment of ulcerative colitis, including data from early clinical trials and the potential clinical impact of future entities...
  26. ncbi request reprint Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California San Francisco, San Francisco, California 94115, USA
    Gastroenterology 133:1106-12. 2007
    ..The aim of this study was to determine whether pregnancy outcomes differ between women with and without inflammatory bowel disease (IBD) and to determine what risk factors adversely affect outcomes...
  27. ncbi request reprint Inflammatory bowel disease in pregnancy
    Sunanda Kane
    Division of Gastroenterology, Department of Medicine, University of Chicago, 5841 South Maryland Avenue, MC 4076, Chicago, IL 60637, USA
    Gastroenterol Clin North Am 32:323-40. 2003
    ..Most medications for IBD are safe during pregnancy and breastfeeding, with notable exceptions. Active disease is usually more deleterious than maintaining medical therapy...
  28. doi request reprint Review article: understanding adherence to medication in ulcerative colitis - innovative thinking and evolving concepts
    S V Kane
    Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Mayo Clinic, Rochester, MN, USA
    Aliment Pharmacol Ther 32:1051-8. 2010
    ..In one study, non-adherence was associated with a five-fold increase in the risk of relapse...
  29. ncbi request reprint Thalidomide as "salvage" therapy for patients with delayed hypersensitivity response to infliximab: a case series
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    J Clin Gastroenterol 35:149-50. 2002
    ..Thalidomide appears to be a safe and effective alternative for short-term healing in patients who develop infliximab-induced delayed hypersensitivity reaction and may be an alternative strategy for those at risk...
  30. ncbi request reprint Gender issues in the management of irritable bowel syndrome
    Sunanda Kane
    Department of Medicine, University of Chicago, Illinois, USA
    Int J Fertil Womens Med 50:79-82. 2005
    ..Healthcare providers, regardless of their primary focus, should be aware of these differences and be familiar with general information...
  31. ncbi request reprint American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, USA
    Gastroenterology 131:283-311. 2006
    ..The paper was approved by the Committee on February 22, 2006 and by the AGA Institute Governing Board on April 20, 2006...
  32. ncbi request reprint American gastroenterological association institute medical position statement on the use of gastrointestinal medications in pregnancy
    Uma Mahadevan
    Division of Gastroenterology, Department of Medicine, University of California, San Francisco, USA
    Gastroenterology 131:278-82. 2006
    ..quot; It was approved by the Clinical Practice and Economics Committee on February 22, 2006, and by the AGA Institute Governing Board on April 20, 2006...
  33. ncbi request reprint An open-label study of the human anti-TNF monoclonal antibody adalimumab in subjects with prior loss of response or intolerance to infliximab for Crohn's disease
    William J Sandborn
    Division of Gastroenterology and Hepatology, Mayo Clinic, 200 First Street NW, Rochester, MN 55905, USA
    Am J Gastroenterol 99:1984-9. 2004
    ....
  34. doi request reprint General health maintenance in IBD
    Maria Moscandrew
    Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
    Inflamm Bowel Dis 15:1399-409. 2009
    ..A comprehensive understanding of all of the issues that can affect a patient with IBD throughout their life cycle is important, as it can impact their natural history, medication decisions, and overall outcomes...
  35. ncbi request reprint Acute sinusoidal obstruction syndrome after 6-thioguanine therapy for Crohn's disease
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, IL 60637, USA
    Inflamm Bowel Dis 10:652-4. 2004
    ..We herein report a patient who developed acute sinusoidal obstruction syndrome after 14 months of successful thioguanine treatment. This is the first report of such a complication in an adult treated with 6-TG for active Crohn's disease...
  36. ncbi request reprint Guidelines do help change behavior in the management of osteoporosis by gastroenterologists
    Sunanda Kane
    Department of Medicine, University of Chicago, Chicago, Illinois 60637, USA
    Am J Gastroenterol 101:1841-4. 2006
    ..Our aim was to determine the short-term impact of the guidelines on practice patterns...
  37. ncbi request reprint Possible association between isotretinoin and inflammatory bowel disease
    Deepa Reddy
    Department of Medicine, University of Chicago, Chicago, Illinois, USA
    Am J Gastroenterol 101:1569-73. 2006
    ..Our aim was to perform a systematic examination of reports of IBD associated with isotretinoin use...
  38. ncbi request reprint Maintaining remissions across the lifespan: a roundtable discussion with Crohn's disease experts
    Gary R Lichtenstein
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Inflamm Bowel Dis 10:S11-21. 2004
  39. ncbi request reprint Crohn's is not a 6-week disease: lifelong management of mild to moderate Crohn's disease
    Gary R Lichtenstein
    University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Inflamm Bowel Dis 10:S2-10. 2004
    ..Here we also evaluate the current preferable treatment practices, based on scientifically valid research and collective clinical experience, for the management of mild to moderate Crohn's disease...
  40. doi request reprint Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes
    Deepa Reddy
    Division of Gastroenterology, Mount Sinai Medical Center, One Gustave Levy Place, New York, New York, USA
    Am J Gastroenterol 103:1203-9. 2008
    ....
  41. ncbi request reprint Assessment of reliability and validity of IBD phenotyping within the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) IBD Genetics Consortium (IBDGC)
    Themistocles Dassopoulos
    Johns Hopkins University Meyerhoff Inflammatory Bowel Disease Center, Baltimore MD, USA
    Inflamm Bowel Dis 13:975-83. 2007
    ..Our aim was to determine the reliability and validity of these phenotypic assessments...
  42. ncbi request reprint Tobacco use is associated with accelerated clinical recurrence of Crohn's disease after surgically induced remission
    Sunanda V Kane
    University of Chicago, Chicago IL 60637, USA
    J Clin Gastroenterol 39:32-5. 2005
    ..To study the association between tobacco exposure and postoperative clinical recurrence in Crohn's disease patients and quantify the time to clinical relapse following surgical resection...
  43. ncbi request reprint Crohn's disease involving the gallbladder. case report and review of the literature
    Carlos A Rettally
    Am J Gastroenterol 98:509-11. 2003
  44. ncbi request reprint Novel therapies in the treatment of ulcerative colitis
    Jeffrey A Tuvlin
    Department of Medicine, Division of Gastroenterology, University of Chicago, 5841 South Maryland Ave, MC 4076, Chicago, IL 60637, USA
    Expert Opin Investig Drugs 12:483-90. 2003
    ..This review examines the most recent compounds in development for the treatment of ulcerative colitis, including data from early clinical trials and the potential clinical impact of future entities...
  45. ncbi request reprint Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation
    Sunanda V Kane
    University of Chicago, Chicago, Illinois 60637, USA
    Am J Gastroenterol 98:1309-14. 2003
    ..The aim of this study was to determine the sensitivity and specificity of fecal lactoferrin concentrations for inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) versus healthy controls...
  46. ncbi request reprint Defining complex contributions of NOD2/CARD15 gene mutations, age at onset, and tobacco use on Crohn's disease phenotypes
    Steven R Brant
    The Harvey M and Lyn P Meyerhoff Inflammatory Bowel Disease Center, Dept of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21231, U S A
    Inflamm Bowel Dis 9:281-9. 2003
    ..Multiple factors, particularly IBD family history, tobacco use, age at diagnosis and recently, NOD2 mutant genotypes may influence Crohn's disease (CD) heterogeneity...
  47. ncbi request reprint The efficacy of oral 5-ASAs in the treatment of active ulcerative colitis: a systematic review
    Sunanda V Kane
    University of Chicago, Chicago, Illinois, USA
    Rev Gastroenterol Disord 3:210-8. 2003
    ..Five-ASA products appear to be as effective as sulfasalazine, but available data do not suggest a difference in efficacy between any of the 5-ASA preparations...
  48. ncbi request reprint The effect of a nonabsorbed oral antibiotic (rifaximin) on the symptoms of the irritable bowel syndrome: a randomized trial
    Mark Pimentel
    Cedars Sinai Medical Center, Burns and Allen Research Institute, and University of California, Los Angeles, Geffen School of Medicine, Los Angeles, California 90048, USA
    Ann Intern Med 145:557-63. 2006
    ..Alterations in gut flora may be important in the pathophysiology of the irritable bowel syndrome (IBS)...
  49. doi request reprint Hormonal replacement therapy after menopause is protective of disease activity in women with inflammatory bowel disease
    Sunanda V Kane
    Mayo Clinic, Rochester, Minnesota and University of Chicago, Chicago, Illinois, USA
    Am J Gastroenterol 103:1193-6. 2008
    ..The nature of inflammatory bowel disease (IBD) following menopause has not been previously studied. The aim of this study was to characterize the effect of menopause on disease activity and identify possible modifiers of disease activity...
  50. ncbi request reprint Inflammatory bowel disease characteristics among African Americans, Hispanics, and non-Hispanic Whites: characterization of a large North American cohort
    Geoffrey C Nguyen
    Harvey M and Lyn P Meyerhoff Inflammatory Bowel Disease Center, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
    Am J Gastroenterol 101:1012-23. 2006
    ..This study was undertaken to characterize racial differences in disease phenotype in a predominantly adult population...
  51. ncbi request reprint Epithelial myosin light chain kinase expression and activity are upregulated in inflammatory bowel disease
    Stephanie A Blair
    Department of Pathology, The University of Chicago, Chicago, IL 60637, USA
    Lab Invest 86:191-201. 2006
    ..Therefore, these data show that MLCK expression and enzymatic activity are increased in IBD. Moreover, the correlation with disease activity suggests that MLCK upregulation may contribute to barrier dysfunction and IBD pathogenesis...
  52. pmc IBD and Pregnancy
    Audrey H Calderwood
    Department of Medicine, University of Chicago, Chicago, Illinois, USA
    MedGenMed 6:14. 2004
  53. ncbi request reprint Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn's disease
    Mark S Silverberg
    Department of Medicine, Mount Sinai Hospital IBD Centre, University of Toronto, Toronto, Ontario, Canada
    Eur J Hum Genet 15:328-35. 2007
    ....